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A Prospective Study of Changes in Aneurysm and Graft Length After
Endovascular Exclusion of AAA Using Balloon and Self-expanding
Endograft Systems
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Purpose: longitudinal shrinkage of aneurysms post-endovascular repair, employing unvalidated measurement techniques
has been held to account for endograft disruption. In this study we record changes in aneurysm length, diameter and
volume using the gold standard of calibrated spiral CT angiography (SCTA).
Method: from 179 patients with AAA scanned by SCTA, 68 were selected for endografting. Twenty-seven had PTFE
home-made prostheses while 41 patients had Talent endografts. SCTA was performed on the fifth postoperative day and
6-monthly intervals thereafter. The distance between the lowest renal artery and the aortic bifurcation (VBL – vertical
body length) and the luminal centre line length (LCL) were measured. Maximal sac diameters and volumes were recorded
using 3DCT reconstruction.
Results: significant increase was noted in VBL (3.2) mm for PTFE-treated patients accompanied by an increase in sac
volume at day 5 (12.4 ml). No changes in LCL or maximal diameters were evident. At 1.5 years further lengthening of
both VBL (6.4 mm) and LCL (9.3 mm) was unaccompanied by sac diameter/volume changes. Talent patients – no changes
in VBL or LCL were evident. Volumes and maximal AP and transverse diameters showed marked shrinkage: AP
−11.2 mm; transverse −2.6 mm; volumes by −35.5 ml at 6 months.
Conclusion: with PTFE increase in VBL but not graft length, without concurrent changes in maximal diameters at day
5, is commensurate with increase in sac volume; after 1.5 years graft lengthening overtakes aortic lengthening. In Talent
patients VBL/graft length remained unchanged. There is no evidence for longitudinal aneurysmal contracture. Volumes
and maximal diameters for the Talent endograft but not for PTFE show shrinkage.
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Introduction In their series of 26 patients treated with the Van-
guard endoprosthesis, Harris et al.2 observed short-
As endovascular repair of AAA becomes widely ac- ening of the aorta by as much as 3.1–6.2 mm occurring
cepted, recording the post-operative changes that ac- up to 1 year after implantation. A further complicating
company aneurysm exclusion becomes increasingly feature in this study was concomitant shortening of
more important. Accurate imaging provides a means the endograft after deployment, by as much as 2.4 to
of observing the long-term durability or otherwise of 67.6 mm, which was seen in 94% of their cohort.
the endograft. Endograft damage after deployment Shrinkage of endografts measured immediately after
has recently been described in a number of studies.1–3 deployment has also been described by White et al.5
It has been proposed that this may be due either This study, using both the AneuRx and Vanguard
to longitudinal shortening of the aneurysmal aorta, devices, found shortening by as much as 30 and 40 mm
lengthening of the prosthesis following deployment respectively. In both studies varying degrees of graft
or migration of the endograft from its proximal or component separation, angulation and distal stent mi-
distal anchoring sites.4 Most weight has thus far been gration were observed and ascribed to this supposed
given to the theory that aneurysms shorten lon- shortening process.
gitudinally, a process akin to the contracture of a scar. These observations suffer a number of dis-
advantages. Firstly, the measurement techniques used
were not validated, and secondly the findings are in
∗ Please address all correspondence to: M. Adiseshiah, Consultant conflict with the accepted theories of the pathogenesisSurgeon, Private Patients Wing, University College Hospital, 25
Grafton Way, London WC1E 6AU. of the aneurysmal process.6
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Table 1. Spiral CT protocol used for scanning patients in this
study.
Collimation 5 mm
Table speed 7.5 mm/s
Pitch (scanner rotation 1 per 1.5
second)
Contrast Omnipaque 350 (120–150 ml)
Contrast injection rate (pump 5 ml/s
injection)
Delay to start of scan 21 s
Start level Coeliac axis
Finish level External iliac arteries
Reconstruction interval 2.5 mm
Fluoroscopy, calibrated angiocatheter, intravascular
ultrasound and spiral CT angiography have all been
used to describe changes in linear aneurysm di-
mensions.7 This can contribute further to confusion
between such reports. Comparative studies dem-
onstrate poor agreement of measurements between
calibrated angiocatheter and validated 3D spiral CT
angiography. The former frequently both under and
overestimates vascular channel length.8 Fig. 1. Length measurements made on aneurysms. The vertical body
length was the shortest linear distance between the lowest renalThe aim of this study was to investigate the changes
artery and the aortic bifurcation. The central lumen line length wasin aortic and graft lengths for two populations of measured in 3-dimensional space using electronic markers (Χ)
patients. One group was treated with a first generation placed in the centre of the flow channel from the top stent to the
aortic bifurcation. The distance between each marker was calculatedpre-expanded PTFE graft fixed with Palmaz stents. The
and summed to give this length.second group received fully supported, self-expanding
Talent (World Medical) endograft system. Changes in
aneurysm dimensions post-exclusion were followed • The shortest distance between two points joining
using validated 3D spiral CT angiography. the origin of the lowest renal artery and the aortic
bifurcation (vertical body length).
• The length of the intra-aneurysmal flow channel
(luminal centre line). This was calculated by placing
Patients and Methods markers in the true luminal centre of the aneurysm
or graft and then measuring the distances between
From a total of 179 patients, 68 were treated for AAA the markers starting at the upper margin of the
with two separate endografting systems. There were stent and finishing at the aortic bifurcation. These
59 males and nine women with mean age 72.4 years landmarks were relatively easily identified using
(range 67–92 years). Twenty-seven patients had PTFE a combination of three-dimensional reconstruction
first generation aorto-uni-iliac prostheses while 41 and multiplanar reformation.
patients had Talent endografts: two configurations
were used: aorto-uni-iliac (7 patients) and bifurcated In addition maximal antero–posterior (AP) and
transverse diameters, and aneurysm volume were alsomodular (34 patients). Patients with complications
such as endoleak or requiring conversion to open recorded from each data set. Volumes were calculated
between the lowest renal artery and the bifurcation ofrepair were excluded from the study.
Techniques used for the manufacture of the UCL the aorta using a voxel summation technique with a
segmentation widow of 0 Hounsfield. The SCT scanner(University College London) PTFE endograft system
have been described elsewhere.9,10 The graft was un- (Siemens Somatom plus 4) had been previously cal-
ibrated with six glass phantom aneurysms whose dia-supported throughout its length and fixed at the aortic
neck and one iliac with Palmaz stents. meters and volumes had been calculated using the
accepted physical techniques of pyknometry and elec-Patients had SCTA on the fifth postoperative day
and 6-monthly intervals thereafter using the protocol tronic callipers. In this separate clinical study8 we
assessed the intra- and inter-observer error involvedin Table 1. Two longitudinal distances were measured
and compared for each patient (Fig. 1): in recording these measurements from spiral CT scans
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in our unit. Results were found to lie within acceptable
limits for clinical practice with the coefficient of re-
producibility11 for linear measurements between
2.3–2.5 mm.8
Statistical analysis
All results are displayed as the median with the 25th
and 75th percentiles in mm. Comparison of patient
outcomes within groups was performed using a paired
Wilcoxon sum of ranks test. A Mann–Whitney U-test
was used to compare parameters between the PTFE
and Talent group. A p-value of less than 0.05 was
regarded as attaining significance.
Results
Data from 12 PTFE and 30 Talent patients was available
for analysis up to 3 and 2 years’ follow-up, respectively.
These patients showed no Type I endoleaks or evidence
of late rupture. There were three cases of Type II
endoleak in the PTFE group and five cases in the
Talent group but all resolved spontaneously within 6
Fig. 2. Column scatter graphs showing the change in vertical bodymonths without intervention.
and central lumen line length that occurs after exclusion with PTFE
endograft. Each point represents an individual patient while the
horizontal line represents the median length for each group. p-1. Changes in vertical body length for PTFE-treated
values are in the text.patients
There was a significant (p=0.04) median increase in
initial median value of 116.6 mm (percentiles 111.1 tovertical body length from an initial 111.5 mm (per-
131.8 mm) until 18 months. At this time, median lengthcentiles 103.7 to 125.9 mm) to 114.7 mm at day 5 (106.3
had increased by 16.4 mm to 133.0 mm (127.8 toto 125.4 mm). The increase was seen for 10 out of 12
158.9 mm; p=0.01). The new graft length subsequentlypatients, of which six had a difference greater than
remained unchanged (Table 1). We also measured the2.5 mm, i.e. beyond the range of observer error.
distance between the lowest renal artery and the topThe gradual increase in length continued, becoming
of the top stent. This did not show any significantsignificant (p=0.03) when there was a further median
change excluding graft migration at this site.increase from 119.7 mm (109.1 to 125.8 mm) at 12
months to 126.1 mm (111.9 to 135.7 mm) at 18 months. 3. Changes in maximal diameters and volume for
This occurred in six out of seven patients. Further PTFE-treated patients
change was not seen up to 3 years’ follow-up (Fig. 2). The initial median AP and transverse diameters were
One of our PTFE patients had a saddle embolus 52.2 (percentiles 49.1 to 56.1) and 50.7 (percentiles 46.1
resulting in endograft thrombosis and necessitating an to 58.9) mm respectively. Neither of these showed any
axillo–bifemoral graft after failed thrombolysis. Al- significant change during the course of follow-up. The
though this was the only PTFE patient who had total aneurysm volume increased from 128.5 ml (p=
marked and obvious shrinkage in volume (50% re- 0.02; percentiles 115.1 to 163.7 ml) to 140.9 ml (119.5 to
duction at 1 year), the vertical body length continued 175.8 ml) at day 5 but then remained stable thereafter.
to increase as described. The 3-year values were 126.0 ml (99.65 to 235 ml).
4. Changes in vertical body length for Talent-treated2. Changes in luminal centre line length for PTFE-
treated patients patients
The initial median length for Talent-treated patientsIn contrast to vertical body length, there was no sig-
nificant change in luminal centre line length from the was 123 mm (percentiles 104.5 to 133.2 mm). This did
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6. Changes in maximal diameters and volume for
Talent-treated patients
Starting median aneurysm volume and maximal dia-
meters did not differ significantly from their cor-
responding values in the PTFE-treated group
(Mann–Whitney U-test).
The initial median AP and transverse diameters
were 55.3 (percentiles 44.6 to 61.0) and 53.9 (percentiles
49.4 to 66.3) mm, respectively. Neither of these showed
any significant change until 6 months’ follow-up when
there were reductions to 44.1 (p=0.01; percentiles 40.9
to 53.5) and 51.3 (p=0.01; percentiles 43.4 to 59.1) mm
respectively. Further decreases continued for 2 years
when median AP and transverse diameters were
30.1 mm (28.7 to 45.7 mm) and 32.0 mm (26.4 to
50.1 mm) but these values did not reach significance
when compared to the preceding months’ value. The
total aneurysm volume increased from 179.3 ml (per-
centiles 136.9 to 266.7 ml; p=0.02) to 194.4 ml (153.3
to 273.8 ml) at day 5. Subsequently a significant (p=
0.01) shrinkage in volume to 143.8 ml (percentiles 91.9
to 188.5 ml) was seen at 6 months. While further
decreases in aneurysm volume continued to the con-
clusion of the study, these did not reach significance
when compared with one another. The 2-year values
at the conclusion of the study were 88.53 ml (66.43 to
160.3 ml; p=0.9).
Discussion
Aneurysm formation is a continuous process char-
Fig. 3. Graphs showing the change in vertical body and central lumen acterised by destruction and loss of aortic elastin and
line length that occurs after exclusion with the Talent endograft. collagen. Biochemical analysis of AAA tissue hasThe horizontal line indicates the median length while the points
shown significant alterations in collagen and elastinrepresent individual patients. p-values are in the text.
content along with activation of many proteolytic en-
zymes.12,13 No more elastin is formed after em-
bryogenesis14, thus reducing amounts further. Since
not significantly differ from the PTFE group pre- both collagen and elastin are essential components
operative lengths (Mann–Whitney U-test). Although, of fibrous tissue, it is difficult to understand how
there was an apparent decrease in aneurysm length aneurysm contracture and cicatrisation can occur. On
at 1 year, this failed to reach significance (Fig. 3). When the contrary, one would expect lengthening and in-
Talent patients with the aorto-uni-iliac configuration creasing tortuosity of the aortoiliac segment and other
were analysed as a separate group, the results re- arteries with time. This is borne out by simple ob-
mained unaltered. servation in vascular surgical practice.15 This phe-
nomenon accounts for the frequent findings of
elongation and tortuosity of the iliac arteries that make5. Changes in luminal centre line length for Talent-
treated patients for difficulties of access in endoluminal repair.
During embryonic and pre-adult development, theThe initial length in the Talent group was 130.6 mm
(percentiles 113.4 to 139.7 mm). This also did not differ aorta is tethered to the vertebrae between the arch
and the bifurcation. As the individual grows, aorticsignificantly from the PTFE-treated initial length
(Mann–Whitney U-test). There was no significant lengthening does not keep pace with musculoskeletal
growth. This differential sets up a considerable lon-change in graft length after treatment (Fig. 3) for the
study period (2 years). gitudinal stretch in the adult. For example, when the
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upper thoracic aorta is removed at post mortem from Talent grafts remained relatively unaltered at 1-year
post-implantation.17subjects less than 35 years of age, it undergoes an
Our study is not unique in showing an increase inimmediate retraction to at least 22% of its original
aneurysm length with time. Studies looking at changeslength.16 The retraction lessens with age due to the
in neck length after both endovascular18,19 and opennormal remodelling of the aortic wall as a result of
repair,20 also show significant increases in neck lengthcollagen and elastin loss and a resultant increase in
from 2 to 10 mm over follow-up intervals extendinglength of the aorta. If further shortening were to
between 1 and 10 years, respectively.occur, the ageing aorta should continue to retract after
Based on these results and explanations, it is unlikelydivision, but the opposite phenomenon is observed.
that prosthesis distortion or disruption can be at-Employing the gold standard of spiral CT angio-
tributed to aneurysm length contracture. We foundgraphy, which has been validated previously,8 our
evidence of graft and sac lengthening in the caseresults are in keeping with these concepts. A complex
of unsupported PTFE endografts fixed by balloonseries of inter-related changes is seen in both the linear
expandable Palmaz stents. On the other hand, in theand three-dimensional parameters used to record an-
case of a fully supported self-expanding endografteurysm sac morphology.
(Talent), no change in graft or sac length was observed.In the PTFE group there is an immediate increase in
The destructive changes described for some types ofaneurysm length that is not reflected by a simultaneous
endograft3,4 may be due to the physical properties ofincrease in the LCL or graft length. It is unlikely
the graft structure itself and not due to changes in thethat enough collagen/elastin remodelling would have
aortic wall and sac. We are currently in the process ofoccurred within this short interval to produce this
investigating the possibility that differential motionseffect. Another explanation for the increase in an-
between the aneurysm wall and the endograft may beeurysm length may relate to the concomitant changes
responsible for some of these developments. The aortain volume and AP/transverse diameter at day 5 after
is not an inert conduit for carrying blood to organs andsurgery. At this time there is a significant increase in
limbs, but a complex and moving biological structuretotal aneurysm volume in PTFE treated aneurysms,
whose function may interfere with the long-turn in-but no change in diameter. According to the law of
tegrity of an implanted prosthesis in ways which aremass conservation, this increase in length might be
as yet only poorly understood.required to accommodate the increase in volume. This
would result in ‘‘unfolding’’ of the aneurysm thus
apparently increasing its length.
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